showed a trendp < 0.05
Alirocumab treatment showed a trend of increased NF-κB p65 expression across all tested concentrations ( p < 0.05).
Alirocumab treatment showed a trend of increased NF-κB p65 expression across all tested concentrations ( p < 0.05).